|
ALG10B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.942800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.269000E-01 |
| Normal-vs-Stage2 |
5.527200E-01 |
| Normal-vs-Stage3 |
6.556600E-01 |
| Normal-vs-Stage4 |
4.795400E-01 |
| Stage1-vs-Stage2 |
5.637200E-01 |
| Stage1-vs-Stage3 |
6.601000E-01 |
| Stage1-vs-Stage4 |
4.910400E-01 |
| Stage2-vs-Stage3 |
8.874800E-01 |
| Stage2-vs-Stage4 |
6.389600E-01 |
| Stage3-vs-Stage4 |
5.578000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.296600E-01 |
| Normal-vs-AfricanAmerican |
5.283800E-01 |
| Normal-vs-Asian |
1.959830E-02 |
| Caucasian-vs-AfricanAmerican |
9.188600E-01 |
| Caucasian-vs-Asian |
1.147780E-01 |
| AfricanAmerican-vs-Asian |
1.195600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.385400E-01 |
| Normal-vs-Female |
1.186640E-01 |
| Male-vs-Female |
1.939830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.143400E-01 |
| Normal-vs-Extreme_Weight |
5.708600E-01 |
| Normal-vs-Obese |
1.375220E-01 |
| Normal-vs-Extreme_Obese |
6.404200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.262200E-01 |
| Normal_Weight-vs-Obese |
1.866430E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.945200E-01 |
| Extreme_Weight-vs-Obese |
4.877900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.406600E-01 |
| Obese-vs-Extreme_Obese |
3.274400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.742030E-01 |
| Normal-vs-Age(41-60Yrs) |
4.230100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.333200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.482600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.817800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.815800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.270160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.097590E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.702150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.893200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.700500E-02 |
| Normal-VS-Type2 PRCC |
5.740500E-02 |
| Normal-VS-KIRP CIMP |
5.158200E-01 |
| Normal-VS-Unclassified PRCC |
7.130000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.810460E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.546800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.486000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.481200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.963200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.757000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.346000E-01 |
| Normal-vs-N1 |
1.655230E-01 |
| Normal-vs-N2 |
7.907800E-01 |
| N0-vs-N1 |
7.699900E-02 |
| N0-vs-N2 |
6.114800E-01 |
| N1-vs-N2 |
6.225800E-01 |
|
|
